Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential
Kruthi Suvarna, Deeptarup Biswas, Medha Gayathri J. Pai, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Challenges and Opportunities in Clinical Diagnostic Routine of Envenomation Using Blood Plasma Proteomics
Joeliton S. Cavalcante, Denis Emanuel Garcia de Almeida, Micael Saggion Moraes, et al.
Toxins (2023) Vol. 15, Iss. 3, pp. 180-180
Open Access | Times Cited: 5
Changes in the Proteome of Platelets from Patients with Critical Progression of COVID-19
Monika Wolny, Svitlana Rozanova, Cornelius Knabbe, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2191-2191
Open Access | Times Cited: 5
A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors
Ankit Halder, Deeptarup Biswas, Aparna Chauhan, et al.
Clinical Proteomics (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Analysis of COVID-19 severity from the perspective of coagulation index using evolutionary machine learning with enhanced brain storm optimization
Beibei Shi, Hua Ye, Ali Asghar Heidari, et al.
Journal of King Saud University - Computer and Information Sciences (2021) Vol. 34, Iss. 8, pp. 4874-4887
Open Access | Times Cited: 13
CoVProt: Toward a Mass Spectrometry Data Portal for COVID-19 Proteomics Research and Development
Sakshi Rajoria, Sai Rohith Kavuru, Hari Sundar Pyda, et al.
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 1, pp. 24-31
Closed Access | Times Cited: 1
Immunohistochemical Expression of the SERPINA3 Protein in Uterine Fibroids
Mateusz de Mezer, Anna Markowska, Janina Markowska, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 13, pp. 1758-1765
Closed Access | Times Cited: 1
Proteomics, Bioinformatics, and Infectious Diseases
Jennifer Geddes‐McAlister, Florence Roux‐Dalvai, Arnaud Droit
Elsevier eBooks (2024), pp. 465-492
Closed Access | Times Cited: 1
Cytosolic serpins act in a cytoprotective feedback loop that limits ESX-1-dependent death of Mycobacterium marinum -infected macrophages
Esther Nobs, Katie Laschanzky, Kristina Munke, et al.
mBio (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 1
COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments
Ahmed Abdeen Hamed, Tamer E. Fandy, Karolina L. Tkaczuk, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 567-567
Open Access | Times Cited: 8
Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches
Fee Faysal Ahmed, Arnob Dip Das, Mst. Joynab Sumi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Serum Proteomic Analysis for New Types of Long-Term Persistent COVID-19 Patients in Wuhan
Cuidan Li, Liya Yue, Yingjiao Ju, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 7
COV-Drug Target interaction server for Covid-19 Drug Repurposing
Kamal Rawal, Prashant Singh, Robin Sinha, et al.
(2021)
Open Access | Times Cited: 10
Levels of soluble complement regulators predict severity of COVID-19 symptoms
Anna Tierney, Wajd Mohammed Alali, Thomas Allan Scott, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Mass spectrometry and machine learning in the identification of COVID-19 biomarkers
Lucas C. Lázari, Gilberto Santos de Oliveira, Janaína Macedo-da-Silva, et al.
Frontiers in Analytical Science (2023) Vol. 3
Open Access | Times Cited: 3
Detection of Mutant Peptides of SARS-CoV-2 Variants by LC/MS in the DDA Approach Using an In-House Database
Sakshi Rajoria, Ankit Halder, Ishita Tarnekar, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 6, pp. 1816-1827
Closed Access | Times Cited: 3
Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches
Amrita Mukherjee, Ayushi Verma, Surbhi Bihani, et al.
Drug Discovery Today Technologies (2021) Vol. 39, pp. 1-12
Open Access | Times Cited: 8
C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
Melissa Hausburg, Jason S. Williams, Kaysie L. Banton, et al.
Clinical Immunology Communications (2022) Vol. 2, pp. 83-90
Open Access | Times Cited: 5
SnO2-xNx based tpod nanostructure for SARS-CoV2 spike protein detection
Nallin Sharma, Chia-Hung Chi, Deepak Dabur, et al.
Environmental Research (2023) Vol. 234, pp. 116505-116505
Open Access | Times Cited: 2
Exploration of the common pathogenic link between COVID‐19 and diabetic foot ulcers: An in silico approach
Xueyao Cai, Ruijin Yang, Wenjun Shi, et al.
Health Science Reports (2023) Vol. 6, Iss. 11
Open Access | Times Cited: 2
“Multiomics” Approaches to Understand and Treat COVID-19: Mass Spectrometry and Next-Generation Sequencing
Diane Appiasie, Daniel J. Guerra, Kyle Tanguay, et al.
BioChem (2021) Vol. 1, Iss. 3, pp. 210-237
Open Access | Times Cited: 5
Plasma Proteins Associated with COVID-19 Severity in Puerto Rico
Lester J. Rosario-Rodríguez, Yadira M. Cantres-Rosario, Kelvin Carrasquillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5426-5426
Open Access
Proteomics and COVID-19: Recent Trends
Chandni Chandarana, Vipul Prajapati, Vidhi Vashi, et al.
(2024), pp. 283-306
Closed Access
Proteomic Profiling of COVID-19 Patients Sera: Differential Expression with Varying Disease Stage and Potential Biomarkers
Iman Dandachi, Ayodele Alaiya, Zakia Shinwari, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2533-2533
Open Access
ProPickML: Advancing Clinical Diagnostics with Automated Peak Picking in Label-Free Targeted Proteomics
Elloise Coyle, Mickaël Leclercq, Clarisse Gotti, et al.
Journal of Proteome Research (2024)
Closed Access
promor: a comprehensive R package for label-free proteomics data analysis and predictive modeling
Chathurani Ranathunge, Sagar Patel, Lubna Pinky, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3

Scroll to top